A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiative.

Pain

Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA Afferent Pharmaceuticals, San Mateo, CA, USA Clinical Data Interchange Standards Consortium, Austin, TX, USA KAI Research, Inc., Rockville, MD, USA Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA Food and Drug Administration, Silver Springs, MD, USA Desjardins Associates, Maplewood, NJ, USA Johnson & Johnson, Titusville, NJ, USA Merck & Co., Whitehouse Station, NJ, USA Pfizer Inc., Groton, CT, USA AstraZeneca, Wilmington, DE, USA Cephalon, Frazer, PA, USA Eli Lilly & Co., Indianapolis, IN, USA Pacira Pharmaceuticals Inc., Parsippany, NJ, USA Teva Pharmaceuticals, Frazer, PA, USA.

Published: January 2013

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pain.2012.10.014DOI Listing

Publication Analysis

Top Keywords

standard database
4
database format
4
format clinical
4
clinical trials
4
trials pain
4
pain treatments
4
treatments acttion-cdisc
4
acttion-cdisc initiative
4
standard
1
format
1

Similar Publications

Human liver cell-based assays for the prediction of hepatic bile acid efflux transporter inhibition by drugs.

Expert Opin Drug Metab Toxicol

January 2025

Institut de R&D Servier, Paris-Saclay, F-91190 Gif-sur-Yvette, France.

Introduction: Drug-mediated inhibition of bile salt efflux transporters may cause liver injury. In vitro prediction of drug effects toward canalicular and/or sinusoidal efflux of bile salts from human hepatocytes is therefore a major issue, which can be addressed using liver cell-based assays.

Area Covered: This review, based on a thorough literature search in the scientific databases PubMed and Web of Science, provides key information about hepatic transporters implicated in bile salt efflux, the human liver cell models available for investigating functional inhibition of bile salt efflux, the different methodologies used for this purpose, and the modes of expression of the results.

View Article and Find Full Text PDF

Stoma reversal surgery is known for relatively high complication rates. While Enhanced Recovery After Surgery (ERAS) protocols are extensively validated for colorectal surgery, their use in stoma reversal remains underexplored. This systematic review and meta-analysis evaluates clinical outcomes of stoma reversal surgery under ERAS protocols compared to standard care (SC) practices.

View Article and Find Full Text PDF

Purpose: Heart failure (HF) is a disease that leads to approximately 300,000 fatalities annually in Europe and 250,000 deaths each year in the United States. Type 2 Diabetes Mellitus (T2DM) is a significant risk factor for HF, and testing for N-terminal (NT)-pro hormone BNP (NT-proBNP) can aid in early detection of HF in T2DM patients. We therefore developed and validated the HFriskT2DM-HScore, an algorithm to predict the risk of HF in T2DM patients, so guiding NT-proBNP investigation in a primary care setting.

View Article and Find Full Text PDF

Background: Falls are frequently reported within the HSE. The Irish Longitudinal Study on Ageing(TILDA) found that 40% of over 50 s experience a fall in a two year period, with 20% requiring hospital attendance (1). It has been estimated that the cost of injuries related to falls in older people will increase exponentially over the coming years (2).

View Article and Find Full Text PDF

Background: In clinical practice, creative arts therapy is frequently utilized for the treatment of traumatized adults, with reports of favorable outcomes. However, the effectiveness of this intervention in post-traumatic stress disorder (PTSD) treatment has not yet been definitively established through meta-analysis. In this meta-analysis, we aim to assess the effectiveness of creative arts therapy in the management of PTSD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!